School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China.
The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei 230027, China.
Proc Natl Acad Sci U S A. 2022 Apr 5;119(14):e2118656119. doi: 10.1073/pnas.2118656119. Epub 2022 Mar 29.
SignificanceATP8B1 is a P4 ATPase that maintains membrane asymmetry by transporting phospholipids across the cell membrane. Disturbance of lipid asymmetry will lead to the imbalance of the cell membrane and eventually, cell death. Thus, defects in ATP8B1 are usually associated with severe human diseases, such as intrahepatic cholestasis. The present structures of ATP8B1 complexed with its auxiliary noncatalytic partners CDC50A and CDC50B reveal an autoinhibited state of ATP8B1 that could be released upon substrate binding. Moreover, release of this autoinhibition could be facilitated by the bile acids, which are key factors that alter the membrane asymmetry of hepatocytes. This enabled us to figure out a feedback loop of bile acids and lipids across the cell membrane.
ATP8B1 是一种 P4 型 ATP 酶,通过将磷脂跨膜转运来维持膜的不对称性。脂质不对称性的破坏将导致细胞膜失衡,最终导致细胞死亡。因此,ATP8B1 的缺陷通常与严重的人类疾病有关,如肝内胆汁淤积症。目前与辅助非催化伴侣 CDC50A 和 CDC50B 结合的 ATP8B1 复合物的结构揭示了 ATP8B1 的自动抑制状态,这种状态可以在底物结合时释放。此外,这种自动抑制的释放可以通过胆酸来促进,胆酸是改变肝细胞膜不对称性的关键因素。这使我们能够弄清楚细胞膜内外胆酸和脂质的反馈循环。